8-K Announcements
6Material company update
Apr 21, 2026·SEC
Material company update
Mar 2, 2026·SEC
Material company update
Jan 22, 2026·SEC
Intuitive Surgical, Inc.(ISRG)Earnings, Financials & Key Ratios
ISRG•NASDAQ
51.7× P/E·Price updated Jun 19, 2026
AboutIntuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.Show more
- Revenue$10.06B+20.5%
- EBITDA$3.62B+28.9%
- Net Income$2.86B+23.0%
- EPS (Diluted)7.87+22.6%
- Gross Margin66%-2.2%
- EBITDA Margin35.99%+6.9%
- Operating Margin29.27%+4.1%
- Net Margin28.38%+2.0%
- ROE16.57%+6.8%
ISRG Key Insights
Intuitive Surgical, Inc. (ISRG) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Strong 5Y profit CAGR of 21.9%
- ✓FCF machine: 24.7% free cash flow margin
- ✓Strong 5Y sales CAGR of 18.2%
- ✓Good 3Y average ROE of 15.6%
- ✓Healthy 5Y average net margin of 26.5%
✗Weaknesses
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when ISRG posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
ISRG Price & Volume
Intuitive Surgical, Inc. (ISRG) stock price & volume — 10-year historical chart
Loading chart...
ISRG Growth Metrics
Intuitive Surgical, Inc. (ISRG) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years15.49%
5 Years18.22%
3 Years17.39%
TTM21.43%
Profit CAGR
10 Years17.11%
5 Years21.91%
3 Years29.26%
TTM20.31%
EPS CAGR
10 Years16.36%
5 Years21.77%
3 Years29.19%
TTM20.97%
Return on Capital
10 Years16.27%
5 Years14.99%
3 Years15.22%
Last Year16.49%
ISRG Recent Earnings
Intuitive Surgical, Inc. (ISRG) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 12/12 qtrs (100%)●Beat Revenue 11/12 qtrs (92%)
Q2 2026Latest
Apr 21, 2026Metric
Actual
Est
EPS
$2.50+17.9%
$2.12
Rev
$2.8B+5.8%
$2.6B
Q1 2026
Jan 22, 2026Metric
Actual
Est
EPS
$2.53+11.5%
$2.27
Rev
$2.9B+3.7%
$2.8B
Q4 2025
Oct 21, 2025Metric
Actual
Est
EPS
$2.40+20.6%
$1.99
Rev
$2.5B+4.1%
$2.4B
Q3 2025
Jul 22, 2025Metric
Actual
Est
EPS
$2.19+13.5%
$1.93
Rev
$2.4B+3.8%
$2.4B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 21, 2026 | $2.50vs $2.12+17.9% | $2.8Bvs $2.6B+5.8% |
| Q1 2026 | Jan 22, 2026 | $2.53vs $2.27+11.5% | $2.9Bvs $2.8B+3.7% |
| Q4 2025 | Oct 21, 2025 | $2.40vs $1.99+20.6% | $2.5Bvs $2.4B+4.1% |
| Q3 2025 | Jul 22, 2025 | $2.19vs $1.93+13.5% | $2.4Bvs $2.4B+3.8% |
Based on last 12 quarters of dataView full earnings history →
ISRG Peer Comparison
Intuitive Surgical, Inc. (ISRG) competitors in Robotic and computer-assisted surgery — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 SYK | 117.88B | 307.80 | 36.64 | 11.16% | 12.92% | 15.04% | 0.66 | |
 MDT | 101.86B | 79.34 | 21.98 | 3.62% | 13% | 9.49% | 0.59 | |
 BSX | 67.31B | 45.29 | 23.35 | 19.87% | 14.4% | 12.4% | 0.51 | |
 ZBH | 17.22B | 87.97 | 24.78 | 7.2% | 9.05% | 5.77% | 0.59 | |
 HOLX | 16.97B | 76.01 | 30.53 | 1.74% | 13.18% | 11.01% | 0.52 | |
 NVCR | 1.62B | 14.28 | -11.70 | 8.28% | -25.66% | -50.82% | 0.85 | |
 GMED | 10.69B | 79.23 | 20.21 | 16.65% | 18.92% | 13.04% | 0.03 | |
 ATRC | 1.46B | 28.80 | -120 | 14.88% | -0.83% | -0.95% | 0.18 |
Compare ISRG vs Peers
Intuitive Surgical, Inc. (ISRG) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ISRG Income Statement
Intuitive Surgical, Inc. (ISRG) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 3.13B | 3.72B | 4.48B | 4.36B | 5.71B | 6.22B | 7.12B | 8.35B | 10.06B | 10.58B |
Revenue Growth % | 15.7% | 19.03% | 20.25% | -2.68% | 31.01% | 8.97% | 14.49% | 17.24% | 20.51% | 21.43% |
Cost of Goods Sold | 934.8M | 1.12B | 1.37B | 1.5B | 1.75B | 2.03B | 2.39B | 2.72B | 3.42B | 3.57B |
COGS % of Revenue | 29.88% | 30.08% | 30.55% | 34.35% | 30.68% | 32.56% | 33.61% | 32.54% | 34% | - |
Gross Profit | 2.19B▲ 0% | 2.6B▲ 18.7% | 3.11B▲ 19.4% | 2.86B▼ 8.0% | 3.96B▲ 38.4% | 4.2B▲ 6.0% | 4.73B▲ 12.7% | 5.63B▲ 19.1% | 6.64B▲ 17.9% | 7.02B▲ 0% |
Gross Margin % | 70.12% | 69.92% | 69.45% | 65.65% | 69.32% | 67.44% | 66.39% | 67.46% | 66% | 66.29% |
Gross Profit Growth % | 16.08% | 18.69% | 19.43% | -8.01% | 38.35% | 6% | 12.71% | 19.13% | 17.89% | - |
Operating Expenses | 1.14B | 1.4B | 1.74B | 1.81B | 2.14B | 2.62B | 2.96B | 3.29B | 3.7B | 3.79B |
OpEx % of Revenue | 36.42% | 37.72% | 38.76% | 41.56% | 37.43% | 42.09% | 41.59% | 39.34% | 36.73% | - |
Selling, General & Admin | 810.9M | 986.6M | 1.18B | 1.22B | 1.47B | 1.74B | 1.96B | 2.14B | 2.38B | 2.43B |
SG&A % of Revenue | 25.92% | 26.49% | 26.31% | 27.91% | 25.68% | 27.96% | 27.57% | 25.62% | 23.7% | - |
Research & Development | 328.6M | 418.1M | 557.3M | 595.1M | 671M | 879M | 998.8M | 1.15B | 1.31B | 1.36B |
R&D % of Revenue | 10.5% | 11.23% | 12.44% | 13.65% | 11.75% | 14.13% | 14.02% | 13.71% | 13.03% | - |
Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | 1.05B▲ 0% | 1.2B▲ 13.7% | 1.37B▲ 14.6% | 1.05B▼ 23.6% | 1.82B▲ 73.5% | 1.58B▼ 13.4% | 1.77B▲ 12.0% | 2.35B▲ 32.9% | 2.95B▲ 25.4% | 3.22B▲ 0% |
Operating Margin % | 33.71% | 32.21% | 30.69% | 24.09% | 31.89% | 25.35% | 24.8% | 28.12% | 29.27% | 30.45% |
Operating Income Growth % | 11.57% | 13.73% | 14.6% | -23.62% | 73.46% | -13.39% | 12.03% | 32.95% | 25.4% | - |
EBITDA | 1.15B | 1.32B | 1.57B | 1.33B | 2.14B | 1.94B | 2.17B | 2.81B | 3.62B | 3.76B |
EBITDA Margin % | 36.74% | 35.43% | 35.15% | 30.57% | 37.44% | 31.23% | 30.45% | 33.66% | 35.99% | 35.52% |
EBITDA Growth % | 11.17% | 14.78% | 19.3% | -15.37% | 60.47% | -9.13% | 11.64% | 29.59% | 28.88% | 27.37% |
D&A (Non-Cash Add-back) | 95M | 120.1M | 199.7M | 282.5M | 317M | 365.8M | 402.2M | 462M | 677.1M | 536.2M |
EBIT | 1.06B | 1.2B | 1.37B | 1.05B | 1.82B | 1.58B | 1.77B | 2.35B | 2.95B | 3.22B |
Net Interest Income | 41.9M | 80.1M | 127.7M | 157.2M | 69.3M | 29.7M | 192.1M | 324.9M | 365.9M | 360.6M |
Interest Income | 41.9M | 80.1M | 127.7M | 157.2M | 69.3M | 29.7M | 192.1M | 324.9M | 365.9M | 360.6M |
Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Income/Expense | 41.9M | 80.1M | 127.7M | 157.2M | 69.3M | 29.7M | 192.1M | 324.9M | 365.9M | 360.6M |
Pretax Income | 1.1B▲ 0% | 1.28B▲ 16.7% | 1.5B▲ 17.4% | 1.21B▼ 19.7% | 1.89B▲ 56.6% | 1.61B▼ 15.0% | 1.96B▲ 21.9% | 2.67B▲ 36.5% | 3.31B▲ 23.8% | 3.58B▲ 0% |
Pretax Margin % | 35.04% | 34.36% | 33.54% | 27.69% | 33.1% | 25.82% | 27.5% | 32.01% | 32.9% | 33.86% |
Income Tax | 436.5M | 154.5M | 120.4M | 140.2M | 162.2M | 262.4M | 141.6M | 336.3M | 434.8M | 584.4M |
Effective Tax Rate % | 39.81% | 12.08% | 8.01% | 11.62% | 8.58% | 16.33% | 7.23% | 12.58% | 13.13% | 16.31% |
Net Income | 660M▲ 0% | 1.13B▲ 70.9% | 1.38B▲ 22.3% | 1.06B▼ 23.1% | 1.7B▲ 60.7% | 1.32B▼ 22.4% | 1.8B▲ 36.0% | 2.32B▲ 29.2% | 2.86B▲ 23.0% | 2.98B▲ 0% |
Net Margin % | 21.09% | 30.29% | 30.8% | 24.33% | 29.85% | 21.25% | 25.24% | 27.81% | 28.38% | 28.15% |
Net Income Growth % | -10.31% | 70.89% | 22.29% | -23.11% | 60.72% | -22.43% | 35.98% | 29.18% | 22.97% | 20.31% |
Net Income (Continuing) | 670.9M | 1.13B | 1.38B | 1.07B | 1.73B | 1.34B | 1.82B | 2.34B | 2.88B | 3B |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 1.6M | 8.7M | 20.9M | 27.6M | 50.4M | 70.7M | 89.7M | 95.9M | 117.7M | 122.7M |
EPS (Diluted) | 1.89▲ 0% | 3.16▲ 67.2% | 3.85▲ 21.8% | 2.94▼ 23.6% | 4.66▲ 58.5% | 3.65▼ 21.7% | 5.03▲ 37.8% | 6.42▲ 27.6% | 7.87▲ 22.6% | 8.28▲ 0% |
EPS Growth % | -9.13% | 67.2% | 21.84% | -23.64% | 58.5% | -21.67% | 37.81% | 27.63% | 22.59% | 20.97% |
EPS (Basic) | 1.97 | 3.31 | 3.98 | 3.02 | 4.79 | 3.72 | 5.12 | 6.54 | 8.00 | - |
Diluted Shares Outstanding | 348.9M | 356.4M | 358.5M | 360.9M | 365.8M | 362M | 357.4M | 362M | 362.7M | 359.8M |
Basic Shares Outstanding | 335.1M | 341.1M | 346.2M | 351M | 356.1M | 355.7M | 351.2M | 355.2M | 356.9M | 354.9M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
ISRG Balance Sheet
Intuitive Surgical, Inc. (ISRG) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 4.69B | 4.33B | 4.66B | 6.63B | 5.84B | 6.25B | 7.89B | 7.11B | 9.78B | 11.52B |
Cash & Short-Term Investments | 3.85B | 3.06B | 3.22B | 5.17B | 4.23B | 4.12B | 5.22B | 4.01B | 5.93B | 7.98B |
Cash Only | 3.85B | 857.9M | 1.17B | 1.62B | 1.29B | 1.58B | 2.75B | 2.03B | 3.37B | 7.98B |
Short-Term Investments | 0 | 2.21B | 2.05B | 3.55B | 2.94B | 2.54B | 2.47B | 1.99B | 2.57B | 2.51B |
Accounts Receivable | 507.9M | 682.3M | 708.3M | 726.6M | 893M | 1.07B | 1.27B | 1.36B | 1.63B | 1.6B |
Days Sales Outstanding | 59.25 | 66.87 | 57.73 | 60.85 | 57.08 | 62.96 | 64.94 | 59.29 | 59.05 | 51.75 |
Inventory | 241.2M | 409M | 595.5M | 601.5M | 587.1M | 893.2M | 1.22B | 1.49B | 1.84B | 1.95B |
Days Inventory Outstanding | 94.18 | 133.28 | 158.85 | 146.64 | 122.34 | 160.9 | 186.05 | 199.72 | 196.24 | 185.06 |
Other Current Assets | 2.1M | 137.4M | 0 | 0 | 129.6M | 6.1M | 176.7M | 253.7M | 376.4M | 0 |
Total Non-Current Assets | 1.07B | 3.51B | 5.07B | 4.54B | 7.71B | 6.72B | 7.55B | 11.73B | 10.85B | 6.74B |
Property, Plant & Equipment | 613.1M | 812M | 1.27B | 1.58B | 1.88B | 2.37B | 3.54B | 4.78B | 5.34B | 5.45B |
Fixed Asset Turnover | 5.10x | 4.59x | 3.52x | 2.76x | 3.04x | 2.62x | 2.01x | 1.75x | 1.88x | 2.02x |
Goodwill | 201.1M | 240.6M | 307.2M | 336.7M | 343.6M | 348.5M | 348.7M | 347.5M | 370.3M | 613.2M |
Intangible Assets | 26M | 66.7M | 112.1M | 77.4M | 70.5M | 49.8M | 39.1M | 23M | 11.1M | 1.09B |
Long-Term Investments | 1.89B | 1.77B | 2.62B | 1.76B | 4.42B | 2.62B | 2.12B | 5.06B | 3.3B | 14.69B |
Other Non-Current Assets | -1.72B | 194.3M | 329.3M | 426.2M | 562.7M | 660.3M | 597.6M | 369M | 810.8M | -3.46B |
Total Assets | 5.76B▲ 0% | 7.85B▲ 36.3% | 9.73B▲ 24.0% | 11.17B▲ 14.8% | 13.55B▲ 21.4% | 12.97B▼ 4.3% | 15.44B▲ 19.0% | 18.84B▲ 22.0% | 20.63B▲ 9.5% | 20.11B▲ 0% |
Asset Turnover | 0.54x | 0.47x | 0.46x | 0.39x | 0.42x | 0.48x | 0.46x | 0.44x | 0.49x | 0.53x |
Asset Growth % | -11.24% | 36.27% | 24.04% | 14.75% | 21.36% | -4.29% | 19.02% | 22% | 9.52% | 44.32% |
Total Current Liabilities | 1.03B | 820.6M | 1.03B | 965.2M | 1.15B | 1.42B | 1.66B | 1.75B | 2.01B | 663.5M |
Accounts Payable | 82.5M | 100.7M | 123.5M | 81.6M | 121.2M | 147M | 188.7M | 193.4M | 255.1M | 0 |
Days Payables Outstanding | 32.21 | 32.81 | 32.94 | 19.89 | 25.26 | 26.48 | 28.76 | 25.97 | 27.21 | 20.8 |
Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33.5M | 39M | 0 |
Deferred Revenue (Current) | 302.8M | 294.3M | 337.8M | 350.3M | 377.2M | 397.3M | 446.1M | 468.8M | 506.7M | 2.16B |
Other Current Liabilities | 230.7M | 198.4M | 287.3M | 245.4M | 362.1M | 401.6M | 436.4M | 359.6M | 609.4M | 0 |
Current Ratio | 4.55x | 5.28x | 4.53x | 6.86x | 5.08x | 4.40x | 4.76x | 4.07x | 4.87x | 17.36x |
Quick Ratio | 4.31x | 4.78x | 3.95x | 6.24x | 4.57x | 3.77x | 4.02x | 3.22x | 3.96x | 14.43x |
Cash Conversion Cycle | 121.21 | 167.33 | 183.63 | 187.6 | 154.17 | 197.38 | 222.23 | 233.04 | 228.08 | 216.01 |
Total Non-Current Liabilities | 327.1M | 338.6M | 418.3M | 444.6M | 453.7M | 439.3M | 385.5M | 563.7M | 683.3M | 1.85B |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 131.9M | 0 |
Capital Lease Obligations | 0 | 0 | 0 | 0 | 87M | 0 | 0 | 112.5M | 131.9M | 131.9M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 95.4M | 172.5M | 172.5M |
Other Non-Current Liabilities | 308.8M | 305.6M | 390.9M | 412.5M | 329.9M | 398.3M | 339.9M | 301.7M | 155.6M | 1.85B |
Total Liabilities | 1.03B | 1.16B | 1.45B | 1.41B | 1.6B | 1.86B | 2.04B | 2.31B | 2.69B | 2.51B |
Total Debt | 0 | 0 | 76.4M | 0 | 87M | 0 | 0 | 146M | 302.8M | 0 |
Net Debt | -3.85B | -857.9M | -1.09B | -1.62B | -1.2B | -1.58B | -2.75B | -1.88B | -3.07B | -7.98B |
Debt / Equity | - | - | 0.01x | - | 0.01x | - | - | 0.01x | 0.02x | 0.00x |
Debt / EBITDA | - | - | 0.05x | - | 0.04x | - | - | 0.05x | 0.08x | 0.00x |
Net Debt / EBITDA | -3.35x | -0.65x | -0.69x | -1.22x | -0.56x | -0.81x | -1.27x | -0.67x | -0.85x | -2.12x |
Interest Coverage | - | - | - | - | - | - | - | - | - | - |
Total Equity | 4.73B▲ 0% | 6.69B▲ 41.4% | 8.31B▲ 24.2% | 9.79B▲ 17.8% | 12B▲ 22.6% | 11.11B▼ 7.4% | 13.4B▲ 20.6% | 16.53B▲ 23.4% | 17.94B▲ 8.5% | 17.6B▲ 0% |
Equity Growth % | -18.16% | 41.43% | 24.2% | 17.83% | 22.63% | -7.41% | 20.56% | 23.38% | 8.54% | 40.84% |
Book Value per Share | 13.55 | 18.76 | 23.17 | 27.12 | 32.81 | 30.70 | 37.49 | 45.66 | 49.47 | 48.91 |
Total Shareholders' Equity | 4.73B | 6.68B | 8.28B | 9.76B | 11.95B | 11.04B | 13.31B | 16.43B | 17.82B | 17.6B |
Common Stock | 100K | 100K | 100K | 100K | 400K | 400K | 400K | 400K | 400K | 400K |
Retained Earnings | 61.4M | 1.52B | 2.49B | 3.26B | 4.76B | 3.5B | 4.74B | 6.8B | 7.01B | 6.4B |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -15.5M | -13.3M | 12.4M | 24.9M | -24.2M | -162.5M | -12.2M | -51.3M | 43.3M | 16.5M |
Minority Interest | 1.6M | 8.7M | 20.9M | 27.6M | 50.4M | 70.7M | 89.7M | 95.9M | 117.7M | 122.7M |
ISRG Cash Flow Statement
Intuitive Surgical, Inc. (ISRG) cash flow — operating, investing & free cash flow history
| Metric | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | 1.14B | 1.17B | 1.6B | 1.48B | 2.09B | 1.49B | 1.81B | 2.42B | 3.03B | 3.36B |
Operating CF Margin % | 36.56% | 31.41% | 35.69% | 34.07% | 36.59% | 23.96% | 25.46% | 28.91% | 30.11% | - |
Operating CF Growth % | 9.68% | 2.25% | 36.65% | -7.1% | 40.72% | -28.65% | 21.67% | 33.15% | 25.49% | 99.62% |
Net Income | 660M | 1.13B | 1.38B | 1.07B | 1.73B | 1.34B | 1.82B | 2.34B | 2.88B | 2.98B |
Depreciation & Amortization | 99.1M | 122.8M | 203M | 276.2M | 310.2M | 365.8M | 435.2M | 462M | 677.1M | 736.2M |
Stock-Based Compensation | 209.1M | 261.2M | 335.8M | 395.4M | 449.2M | 513.2M | 598.2M | 676.8M | 788.2M | 812.5M |
Deferred Taxes | 62.9M | 31.9M | -8M | 57.6M | -62.6M | -185.3M | -280.8M | -135.3M | 19.1M | 358.3M |
Other Non-Cash Items | 21.2M | 12.4M | 7.1M | -38M | 32.6M | 71.8M | 21.5M | -6.7M | -58.2M | -1.73B |
Working Capital Changes | 91.6M | -383.7M | -321.5M | -273.2M | -368.1M | -619.1M | -777.6M | -919.3M | -1.27B | 190.9M |
Change in Receivables | -81.7M | -161.3M | 38.8M | 5.7M | -142.3M | -159.3M | -186.3M | -95.9M | -301.7M | -280.2M |
Change in Inventory | -115.5M | -279M | -360.5M | -170.1M | -256M | -546.6M | -712.5M | -830M | -1.06B | -1.12B |
Change in Payables | 14M | 16.7M | 12.3M | -32.3M | 36M | 21.3M | 41.7M | -400K | 57.9M | 48.7M |
Cash from Investing | 378.7M | -1.05B | -1.15B | -940.6M | -2.46B | 1.37B | -360.1M | -3.27B | 665.8M | -462.2M |
Capital Expenditures | -190.7M | -187.4M | -425.6M | -341.5M | -353.5M | -532.4M | -1.06B | -1.11B | -539.8M | -526.5M |
CapEx % of Revenue | 6.09% | 5.03% | 9.5% | 7.84% | 6.19% | 8.56% | 14.94% | 13.3% | 5.36% | 4.98% |
Acquisitions | 190.7M | -87.9M | -59.7M | -37.7M | -8.7M | -12.8M | -8.9M | -1M | -13.9M | -12.7M |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | -190.7M | -774.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -483.4M |
Cash from Financing | -1.91B | 126.3M | -168.4M | -85.7M | 43M | -2.57B | -287.6M | 150.9M | -2.36B | -3.48B |
Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Equity Issued (Net) | -1.86B | 236.6M | -269.5M | 174.5M | 276.5M | -2.37B | -416.3M | 429.4M | -1.95B | -2.08B |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | -2.27B | 0 | -269.5M | -134.3M | 0 | -2.61B | -416.3M | 0 | -2.3B | -3.42B |
Other Financing | -54.6M | -110.3M | 101.1M | -260.2M | -233.5M | -198.7M | 128.7M | -278.5M | -419.1M | -1.4B |
Net Change in Cash | -388.4M▲ 0% | 246.2M▲ 163.4% | 273.2M▲ 11.0% | 455.9M▲ 66.9% | -332.5M▼ 172.9% | 294.7M▲ 188.6% | 1.17B▲ 296.8% | -707.7M▼ 160.5% | 1.34B▲ 290.1% | -561.6M▲ 0% |
Free Cash Flow | 953.2M▲ 0% | 982.2M▲ 3.0% | 1.17B▲ 19.4% | 1.14B▼ 2.5% | 1.74B▲ 51.8% | 958.4M▼ 44.8% | 749.6M▼ 21.8% | 1.3B▲ 73.9% | 2.49B▲ 91.0% | 2.83B▲ 0% |
FCF Margin % | 30.46% | 26.37% | 26.18% | 26.23% | 30.4% | 15.4% | 10.52% | 15.61% | 24.75% | 26.78% |
FCF Growth % | -3.62% | 3.04% | 19.39% | -2.5% | 51.83% | -44.79% | -21.79% | 73.93% | 91.03% | 62.4% |
FCF per Share | 2.73 | 2.76 | 3.27 | 3.17 | 4.75 | 2.65 | 2.10 | 3.60 | 6.87 | 7.88 |
FCF Conversion (FCF/Net Income) | 1.73x | 1.04x | 1.16x | 1.40x | 1.23x | 1.13x | 1.01x | 1.04x | 1.06x | 0.95x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Taxes Paid | 147.5M | 179.2M | 0 | 0 | 0 | 444.2M | 447.8M | 466.5M | 537.9M | 0 |
ISRG Key Ratios
Intuitive Surgical, Inc. (ISRG) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | 12.56% | 19.76% | 18.4% | 11.72% | 15.65% | 11.44% | 14.67% | 15.52% | 16.57% | 16.89% |
Return on Invested Capital (ROIC) | 86.83% | 26.81% | 15.81% | 10.24% | 14.41% | 11.64% | 13.13% | 13.93% | 14.96% | 18.15% |
Gross Margin | 70.12% | 69.92% | 69.45% | 65.65% | 69.32% | 67.44% | 66.39% | 67.46% | 66% | 66.29% |
Net Margin | 21.09% | 30.29% | 30.8% | 24.33% | 29.85% | 21.25% | 25.24% | 27.81% | 28.38% | 28.15% |
Debt / Equity | - | - | 0.01x | - | 0.01x | - | - | 0.01x | 0.02x | 0.00x |
FCF Conversion | 1.73x | 1.04x | 1.16x | 1.40x | 1.23x | 1.13x | 1.01x | 1.04x | 1.06x | 0.95x |
Revenue Growth | 15.7% | 19.03% | 20.25% | -2.68% | 31.01% | 8.97% | 14.49% | 17.24% | 20.51% | 21.43% |
Related:ISRG Dividend History·ISRG Revenue History·ISRG Price History·ISRG P/E History·ISRG Financial Ratios·ISRG Institutional Holders
ISRG SEC Filings & Documents
Intuitive Surgical, Inc. (ISRG) SEC filings — annual & quarterly reports (10-K, 10-Q)
ISRG Frequently Asked Questions
Intuitive Surgical, Inc. (ISRG) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Intuitive Surgical, Inc. (ISRG) reported $10.58B in revenue for fiscal year 2025. This represents a 103728% increase from $10.2M in 1999.
Intuitive Surgical, Inc. (ISRG) grew revenue by 20.5% over the past year. This is strong growth.
Yes, Intuitive Surgical, Inc. (ISRG) is profitable, generating $2.98B in net income for fiscal year 2025 (28.4% net margin).
Dividend & Returns
Intuitive Surgical, Inc. (ISRG) has a return on equity (ROE) of 16.6%. This is reasonable for most industries.
Intuitive Surgical, Inc. (ISRG) generated $2.83B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.